公开(公告)号：US20220175858A1

公开(公告)日：2022-06-09

申请号：US17673488

申请日：2022-02-16

申请人： KoBioLabs, Inc.

发明人： Woo Ri Ko ,  June Chul Lee ,  Hyo In Park ,  Tae Wook Nam ,  Gwang Pyo Ko ,  Woon Ki Kim ,  Dae Hee Han ,  In Su Kim ,  Jin Woo Lee ,  Hye Jin Kim

IPC分类号： A61K35/747 ,  A23L33/135 ,  A61K8/02

摘要： A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.

公开(公告)号：US11285183B2

公开(公告)日：2022-03-29

申请号：US17102301

申请日：2020-11-23

申请人： KoBioLabs, Inc.

发明人： Woo Ri Ko ,  June Chul Lee ,  Hyo In Park ,  Tae Wook Nam ,  Gwang Pyo Ko ,  Woon Ki Kim ,  Dae Hee Han ,  In Su Kim ,  Jin Woo Lee ,  Hye Jin Kim

IPC分类号： A61K35/747 ,  A23L33/135 ,  A61K8/02

摘要： A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.

公开(公告)号：US11819526B2

公开(公告)日：2023-11-21

申请号：US17673488

申请日：2022-02-16

申请人： KoBioLabs, Inc.

发明人： Woo Ri Ko ,  June Chul Lee ,  Hyo In Park ,  Tae Wook Nam ,  Gwang Pyo Ko ,  Woon Ki Kim ,  Dae Hee Han ,  In Su Kim ,  Jin Woo Lee ,  Hye Jin Kim

IPC分类号： A61K35/747 ,  A23L33/135 ,  A61K8/02

CPC分类号： A61K35/747 ,  A23L33/135 ,  A61K8/0208

摘要： A strain of Lactobacillus gasseri KBL697 and the use thereof are described. The strain of Lactobacillus gasseri KBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.